3Molinaro E,Viola D,Passannanti P,et al.Recombinant human TSH(rhTSH) in 2009:new perspectives in diagnosis and therapy[J].Q.J Nucl Med Mol Imaging,2009,53(5):490-502.
9Ⅵ S,INGOE L,KEEKA G,et al.The beneficial effectofL-thyroxine on cardiovascular risk factors,endothelial function,and quality of life in subclinical hypothyroidism;randomizcd,cross over trial[J].J Clin Endocrinol Metab,2007,92 (5):1715-1723.
6Perros P,McCrimmon RJ,Shaw G.et al.Frequency of thyroid dysfunction in diabetic patients:value of annual screening.Diabet Med,1995,12:622-27.
7Feely J,Isles TE.Screen for thyroid dysfunction in diabetics.Br Med J,1979,285:1678.
8Chen HS,Wu TE,Jap TS,et al.Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients.Diabet Med,2007,24:1336-1344.
9Kahaly GJ.Cardiovascular and atherogenic aspects of subclinical hypothyroidism.Thyroid,2000,10:665-679.
10Ochs N,Auer R.Bauer DC,et al.Meta-analysis:subclinical thyroid dysfunction and the risk for coronary heart disease and mortality.Ann Intern Med,2008,148:832-845.
